Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data? Read more in EHJ! http://ow.ly/uNXC50GuROo
#gout #XOR #uricacid #CVD #inflammation #cardiotwitter @escardio @ESC_Journalspic.twitter.com/9nDivxnv5M
Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data? Read more in EHJ! http://ow.ly/uNXC50GuROo
#gout #XOR #uricacid #CVD #inflammation #cardiotwitter @escardio @ESC_Journalspic.twitter.com/9nDivxnv5M
What’s the impact of COVID-19 pandemic restrictions on STEMI? New insights from a cardiac magnetic resonance imaging study just published in EHJ! http://ow.ly/zysK50GuRC8
#COVID19 #STEMI #myocardium #damage #CMR #imagefirst #cardiotwitter @escardio @ESC_Journalspic.twitter.com/kwtAR8IfLd
Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION in EHJ! http://ow.ly/aHyW50Gu809
#pregnancy #hypertension #CONCEPTION #preeclampsia #cardiotwitter @escardio @ESC_Journalspic.twitter.com/Xo5BoeqHRw
Early diagnosis of cardiac allograft vasculopathy: biopsy, liquid biopsy, non-invasive imaging, coronary imaging, or coronary physiology? http://ow.ly/6yYP50Gu7PL
#allograftvasculopathy #biopsy #imaging #physiology #cardiotwitter @escardio @ESC_Journalspic.twitter.com/h2EIRbJafO
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. New insights from an international multicentre registry in EHJ! http://ow.ly/tivY50Gu7Lh
#allograftvasculopathy #FFR #MVD #prognosis #cardiotwitter @escardio @ESC_Journalspic.twitter.com/feKHuXWxyt
Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score
Read more in #EHJ
#cardiotwitter @escardio
https://academic.oup.com/eurheartj/article/42/39/4053/6372957 …pic.twitter.com/egWapXhwgS
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document
#EHJ #cardiotwitter @escardio
https://academic.oup.com/eurheartj/article/42/39/4013/6323985 …pic.twitter.com/3jUoJBpoez
The legs are a pathway to the heart: connections between chronic venous insufficiency and cardiovascular disease
#EHJ @escardio #cardiotwitter
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehab589/6390831 …pic.twitter.com/NFwVP8w3UT
Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study
@escardio #EHJ #cardiotwitter
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehab686/6395270 …pic.twitter.com/N3dLNTD5XU
Ciraparantag as a potential universal anticoagulant reversal agent
#EHJ #cardiotwitter @escardio
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehab706/6397003 …pic.twitter.com/RjXnCrQB3a
Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis. Read more in #EHJ
#cardiotwitter @escardio
https://academic.oup.com/eurheartj/article/42/39/4077/6323689 …pic.twitter.com/84EAUZ5Yjh
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial
#EHJ #CardioTwiter @escardio
https://academic.oup.com/eurheartj/article/42/39/4040/6357238 …pic.twitter.com/yhq92sCMuE
EHJ Issue 42-39 – Here is our video announcement!
Don’t miss this focus issue on thrombosis and antithrombotic treatment. Stay up-to-date with EHJ!
#cardiotwitter @ESC_Journals @escardiopic.twitter.com/gI4pGBJdu5
Maternal and neonatal complications in women with congenital heart disease: a nationwide analysis
@escardio #EHJ #CardioTwitter
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehab571/6390149 …pic.twitter.com/XlexdAOQrw
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy
@escardio #EHJ #cardiotwitter #HCM
https://academic.oup.com/eurheartj/article/42/38/3932/6365852 …pic.twitter.com/jWvGHqCjy5
Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum
#EHJ #Cardiotwitter @escardio https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehab642/6384672 …
Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence
#EHJ #CardioTwitter @escardio
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehab680/6387453 …pic.twitter.com/5oZPM093Zb
Combination lipid-lowering therapy as first-line strategy in very high-risk patients
#EHJ #CardioTwitter @escardio
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehab718/6390842 …pic.twitter.com/rsg5Z3eZSg
Artificial intelligence in the diagnosis and management of arrhythmias. Read more in #EHJ
#cardiotwitter @escardio #ai #artificialintelligence
https://academic.oup.com/eurheartj/article/42/38/3904/6352590 …pic.twitter.com/w6Ditr8XnZ
